Russian Pharmaceutical Substances are in Demand
Russian Pharmaceutical Company “Pharmamed.RF” having modernized and extended its manufacturing capacities, obtained licenses for manufacture of pharmaceutical substances according to GMP requirements and now it is replenishing its portfolio.
Substances offered at the pharma market are of high quality and are in demand of drug manufacturers. It concerns, in the first place, Meldonium (FS 001217-300915) and Methyl ethylpiridinol hydrochloride (FS 001259-021115). Based on Meldonium (metabolic agent normalizing energy cell metabolism), vital and life-saving drugs are manufactured, including Mildronat, Cardionat and Angiocardin. Based on Methyl ethylpirridinol hydrochlorie – retinoprotective agent, protecting retina from highly intensive light, resolving intraocular hemorrhages, reducing capillary permeability, inhibiting blood coagulation, increasing brain resistance to hypoxia and ischaemia – Emoxipin, Cardioxipin, Emoxibel are produced.